Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease

By sjmartinez • April 6, 2023

Patel S, Lam PH, Kanonidis E, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A. Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease. Am J Med. 2023 Apr 3:S0002-9343(23)00205-X. doi: 10.1016/j.amjmed.2023.03.017. Epub ahead of print. PMID: 37019372.

Tags: advanced kidney disease, Cardiology/Epi, heart failure, Hospitalization, mortality, Publications, renin-angiotensin system inhibitors

Impact of Nonalcoholic Hepatic Steatosis on the Warranty Period of a Coronary Artery Calcium Score of 0: Results From the Multi-Ethnic Study of Atherosclerosis

Ichikawa K, Lim J, McClelland RL, Susarla S, Krishnan S, Benzing T, Kianoush S, Aldana-Bitar J, Manubolu VS, Budoff MJ. Impact of Nonalcoholic Hepatic Steatosis[...]

Diet and risk of atrial fibrillation: a systematic review

Gawałko M, Middeldorp ME, Saljic A, Penders J, Jespersen T, Albert CM, Marcus GM, Wong CX, Sanders P, Linz D. Diet and risk of atrial[...]

Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection

Cyktor JC, Yeh E, Ribaudo H, Hoeth D, Naqvi A, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Tawakol A, Lederman MM, Stein[...]